Literature DB >> 7125634

Measurements of serum gentamycin levels by rapid tests.

S M Qadri, R L Gillum, D Boyd.   

Abstract

Gentamicin is a very useful antimicrobial agent for the treatment of serious infections caused by gram-negative bacteria. However, it's low therapeutic index and potential ototoxic and nephrotoxic side effects necessitate frequent determinations of serum concentration to assist in maintaining therapeutic levels and avoiding toxic levels. Two bioassays and a latex agglutination inhibition card (LAIC) test were evaluated to determine gentamicin levels in nearly 100 patient sera. Results were compared with a radioimmunoassay (RIA). Two bioassays, the Bio-Monitor and the GentaSak, gave correlation coefficients of 0.987 and 0.982, respectively. The correlation coefficient for the LAIC test was 0.987. All three tests compared well with RIA in accurately detecting gentamicin levels in patients as well as simulated sera. The LAIC test, however, was more rapid, giving results within half an hour whereas bioassays required 6--8 hours for completion. The LAIC test was also found to be more economical. It provides a suitable alternative to RIA procedures in small laboratories and for performing 'stat' tests since batching is not necessary.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125634     DOI: 10.1007/bf00400381

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  17 in total

1.  Enzymatic assay for gentamicin and related aminoglycoside antibiotics.

Authors:  R K Holmes; J P Sanford
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

2.  A rapid chemical assay for gentamicin.

Authors:  D H Smith; B Van Otto; A L Smith
Journal:  N Engl J Med       Date:  1972-03-16       Impact factor: 91.245

3.  Radioimmunoassay of an antibiotic: gentamicin.

Authors:  J E Lewis; J C Nelson; H A Elder
Journal:  Nat New Biol       Date:  1972-10-18

4.  "Homogeneous" enzyme immunoassay. A new immunochemical technique.

Authors:  K E Rubenstein; R S Schneider; E F Ullman
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

5.  Possible nephrotoxicity of gentamicin.

Authors:  R G Schultze; R E Winters; H Kauffman
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States.

Authors:  G G Jackson; G Arcieri
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Clinical research experience with gentamicin. Incidence of adverse reactions.

Authors:  G M Arcieri; F G Falco; H M Smith; L B Hobson
Journal:  Med J Aust       Date:  1970-06-13       Impact factor: 7.738

8.  Rapid, reproducible enzyme immunoassay for gentamicin.

Authors:  D Phaneuf; E Francke; H C Neu
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

9.  Experimental ototoxicity of gentamicin in squirrel monkeys.

Authors:  M Igarashi; P G Lundquist; B R Alford; H Miyata
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

10.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.